These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 35538576)

  • 1. Patient-derived xenograft (PDX) models, applications and challenges in cancer research.
    Abdolahi S; Ghazvinian Z; Muhammadnejad S; Saleh M; Asadzadeh Aghdaei H; Baghaei K
    J Transl Med; 2022 May; 20(1):206. PubMed ID: 35538576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-derived xenograft models: an emerging platform for translational cancer research.
    Hidalgo M; Amant F; Biankin AV; Budinská E; Byrne AT; Caldas C; Clarke RB; de Jong S; Jonkers J; Mælandsmo GM; Roman-Roman S; Seoane J; Trusolino L; Villanueva A
    Cancer Discov; 2014 Sep; 4(9):998-1013. PubMed ID: 25185190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Generation and Application of Patient-Derived Xenograft Model for Cancer Research.
    Jung J; Seol HS; Chang S
    Cancer Res Treat; 2018 Jan; 50(1):1-10. PubMed ID: 28903551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models.
    Okada S; Vaeteewoottacharn K; Kariya R
    Cells; 2019 Aug; 8(8):. PubMed ID: 31412684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-derived xenograft models for personalized medicine in colorectal cancer.
    Xie J; Lin Y
    Clin Exp Med; 2020 May; 20(2):167-172. PubMed ID: 32100151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study.
    Xu C; Yan L; An Q; Zhang S; Guan X; Wang Z; Lv A; Liu D; Liu F; Dong B; Zhao M; Tian X; Hao C
    Int J Med Sci; 2022; 19(8):1241-1253. PubMed ID: 35928724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization.
    Sun S; Zhang Z
    Front Med; 2016 Mar; 10(1):104-10. PubMed ID: 26926009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Knowledge and practice of patient-derived xenograft models in leukemia].
    Kato I
    Rinsho Ketsueki; 2022; 63(9):1335-1343. PubMed ID: 36198560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-Derived Xenograft Models in Breast Cancer Research.
    Na D; Moon HG
    Adv Exp Med Biol; 2021; 1187():283-301. PubMed ID: 33983584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-derived xenografts: a valuable platform for clinical and preclinical research in pancreatic cancer.
    Wang Y; Cui J; Wang L
    Chin Clin Oncol; 2019 Apr; 8(2):17. PubMed ID: 30943729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Derived Xenograft Models for Translational Prostate Cancer Research and Drug Development.
    Philp LK
    Methods Mol Biol; 2024; 2806():153-185. PubMed ID: 38676802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of patient-derived tumor xenograft models and tumor organoids.
    Yoshida GJ
    J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of patient-derived tumor xenografts in cancer treatment.
    Sia D; Moeini A; Labgaa I; Villanueva A
    Pharmacogenomics; 2015; 16(14):1671-83. PubMed ID: 26402657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-Derived Xenografts: Historical Evolution, Immunocompromised Host Models, and Translational Significance.
    Thompson J; Saad MI
    Methods Mol Biol; 2024; 2806():1-8. PubMed ID: 38676791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Review of Patient-Derived Xenograft Models for Preclinical Studies of Anti-Cancer Drugs in Solid Tumors.
    Koga Y; Ochiai A
    Cells; 2019 May; 8(5):. PubMed ID: 31064068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-derived xenografts as in vivo models for research in urological malignancies.
    Inoue T; Terada N; Kobayashi T; Ogawa O
    Nat Rev Urol; 2017 May; 14(5):267-283. PubMed ID: 28248952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models.
    Prasetyanti PR; van Hooff SR; van Herwaarden T; de Vries N; Kalloe K; Rodermond H; van Leersum R; de Jong JH; Franitza M; Nürnberg P; Todaro M; Stassi G; Medema JP
    Int J Cancer; 2019 Jan; 144(2):366-371. PubMed ID: 30151914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in building clinically relevant patient-derived tumor xenograft models for cancer research.
    Wang W; Li Y; Lin K; Wang X; Tu Y; Zhuo Z
    Animal Model Exp Med; 2023 Oct; 6(5):381-398. PubMed ID: 37679891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-derived xenograft models in cancer therapy: technologies and applications.
    Liu Y; Wu W; Cai C; Zhang H; Shen H; Han Y
    Signal Transduct Target Ther; 2023 Apr; 8(1):160. PubMed ID: 37045827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine.
    Rivera M; Fichtner I; Wulf-Goldenberg A; Sers C; Merk J; Patone G; Alp KM; Kanashova T; Mertins P; Hoffmann J; Stein U; Walther W
    Neoplasia; 2021 Jan; 23(1):21-35. PubMed ID: 33212364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.